Clinical and economic impact model of blood-based biomarkers in cancer risk assessment of pulmonary nodules (PNs) from a health-system perspective

Cancer Treatment and Research Communications · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles